IP Library Granted Patent US 10,369,200
Granted Patent B2
US 10,369,200 · App. 15/252,032 · Granted Aug 6, 2019

Platelet activation and growth factor release using electric pulses

Inventors: Vasile Bogdan Neculaes (Niskayuna, NY); Andrew Soliz Torres (Niskayuna, NY); Antonio Caiafa (Albany, NY); Brian Dun-Lan Lee (Rexford, NY); Allen Lawrence Garner (West Layfayette, IN)
Assignee: GENERAL ELECTRIC COMPANY
A61K38/1858A61K35/19C12N13/00G01N33/48707G01N33/49
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,369,200
App. No.
15/252,032
Granted
Aug 6, 2019
Kind
B2
Abstract

Methods and systems for releasing growth factors are disclosed. In certain embodiments, a blood sample is exposed to a sequence of one or more electric pulses to trigger release of a growth factor in the sample. In certain embodiments, the growth factor release is not accompanied by clotting within the blood sample.

Claims (12)

1. A method for releasing growth factors, comprising:

exposing a blood sample to a sequence of one or more electric pulses that trigger release of a growth factor in the blood sample, wherein the growth factor release is not accompanied by clotting within the blood sample.

2. The method of claim 1 , comprising:

collecting the growth factor; and

treating a patient with the growth factor, wherein the blood sample was acquired from the patient.

3. The method of claim 1 , wherein calcium ions are not added to the blood sample prior to exposing the blood sample to the sequence of one or more electric pulses.

4. The method of claim 1 , wherein the method comprises increasing calcium ion concentration and adding an ADP blocking agent to the blood sample prior to exposing the blood sample to the sequence of one or more electric pulses.

5. The method of claim 4 , wherein the ADP blocking chemical comprises apyrase.

6. The method of claim 1 , wherein the one or more electric pulses have an electric field strength between about 0.1 kV/cm and about 350 kV/cm.

7. The method of claim 1 , wherein the one or more electric pulses have pulse durations between about 1 nanosecond and about 100 microseconds.

8. The method of claim 1 , wherein the growth factor comprises platelet derived growth factor.

9. The method of claim 1 , wherein the blood sample is a whole blood sample or a platelet rich plasma.

Assignments (4)
QUITCLAIM ASSIGNMENT Recorded Sep 18, 2025
From: EDISON INNOVATIONS LLC
To: BLUE RIDGE INNOVATIONS, LLC
Reel/Frame 072938/0793 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 26, 2025
From: GENERAL ELECTRIC COMPANY
To: GE INTELLECTUAL PROPERTY LICENSING, LLC
Reel/Frame 070636/0815 →
CHANGE OF NAME Recorded Mar 26, 2025
From: GE INTELLECTUAL PROPERTY LICENSING, LLC
To: DOLBY INTELLECTUAL PROPERTY LICENSING, LLC
Reel/Frame 070643/0907 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 20, 2025
From: DOLBY INTELLECTUAL PROPERTY LICENSING, LLC
To: EDISON INNOVATIONS, LLC
Reel/Frame 070293/0273 →
Continuity (2)
Continuation 14157819 · Jan 17, 2014
Related Publication 20160367633A1 · Dec 22, 2016